Respiratory Medicine Trials

  • 01/10/2019

    THE DESIGN OF A PERSONALISED RISK COMMUNICATION TOOL TO AID PATIENTS’ UNDERSTANDING OF THE POTENTIAL RISKS AND BENEFITS OF LISTING FOR LUNG TRANSPLANTATION

    View Trial
  • 01/09/2018

    CATAPULT Study

    A Phase 1/2 Study to Assess the Safety and Efficacy of MultiStem Therapy in Subjects with Acute Respiratory Distress Syndrome

    View Trial
  • 30/04/2020

    Mechanisms for the susceptibility to bacterial infection in those with influenza

    View Trial
  • 01/08/2019

    A research study to investigate whether transgenic mesenchymal stem cells expressing hydroxysteroid dehydrogenase type-1 can attenuate inflammation in Acute Respiratory Distress Syndrome

    View Trial
  • 01/06/2019

    MA39189

    MULTICENTER INTERNATIONAL DOUBLEBLIND TWO-ARM RANDOMIZED PLACEBOCONTROLLED PHASE II TRIAL OF PIRFENIDONE IN PATIENTS WITH UNCLASSIFIABLE PROGRESSIVE FIBROSING ILD

    View Trial
  • 31/05/2019

    GSK-Birmingham Tissue Collaborative (GB-TC)

    Use of Tissue from Lung Resections to Investigate Molecular and Functional Mechanisms of Human Lung Disease

    View Trial
  • 03/08/2021

    Use of Tissue from Lung Resections to Investigate the Impact of Smoking and Vaping on Cellular Function in Human Lung Disease

    View Trial
  • 31/01/2020

    BronchUK Study

    Bronchiectasis Observational Cohort and Biobank Uk Study

    View Trial
  • 30/09/2021

    The CLEAR Trial

    A 2×2 factorial randomised examiner blind open label trial to determine the Clinical and cost- Effectiveness of hypertonic saline (HTS 6%) and carbocisteine for Airway cleaRance versus usual care over 52 weeks in bronchiectasis

    View Trial
  • 30/06/2017

    Molecular and Functional Mechanisms of Human Lung Disease

    View Trial